A Double-Blind, Randomized Study to Evaluate the Efficacy and Safety of Lapaquistat or Placebo When co-Administered With High Dose Statin Therapy in Subjects With Primary Hypercholesterolemia.
Phase of Trial: Phase III
Latest Information Update: 09 Jun 2013
At a glance
- Drugs Lapaquistat (Primary)
- Indications Hypercholesterolaemia
- Focus Registrational; Therapeutic Use
- Sponsors Takeda Global Research and Development Center
- 31 Aug 2018 Biomarkers information updated
- 24 Mar 2009 Actual patient number (649) added as reported by ClinicalTrials.gov.
- 24 Mar 2009 Planned end date changed from 1 Feb 2007 to 1 Mar 2007 as reported by ClinicalTrials.gov.